HOME >> MEDICINE >> NEWS
Detection of antibodies could identify MS pats who do not respond well to interferon beta

Danish research published in this week's issue of THE LANCET highlights how the detection of antibodies to interferon beta-the first choice treatment for multiple sclerosis patients-could be important in identifying patients who do not respond well to interferon beta, with implications for the provision of alternative drug therapy.

Interferon beta is the first-line treatment for relapsing-remitting multiple sclerosis, but the drug can induce neutralising antibodies against itself, which might reduce its effectiveness. Per Soelberg Sorensen from Copenhagen University Hospital, Denmark, and colleagues measured neutralising antibodies every year for up to five years among 541 patients with multiple sclerosis, randomly selected from all patients who started treatment with interferon beta in Denmark between 1996 and 1999.

The time to first relapse was substantially longer (by 244 days) for patients who were antibody-negative after one year of interferon-beta treatment compared with patients who were antibody-positive. The yearly relapse rate was increased more than 50% in patients who developed antibodies compared with those who did not.

Patients developed neutralising antibodies independent of age, sex, disease duration, and prognosis at the start of treatment. The presence of antibodies did not affect overall disease outcome.

Per Soelberg Sorensen comments: "Our findings suggest that the presence of neutralising antibodies against interferon beta reduces the clinical effect of the drug. In patients who are not doing well on interferon beta, the presence of such antibodies should prompt consideration about a change of treatment to other drug therapies such as glatiramer acetate or mitoxantrone."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
9-Oct-2003


Page: 1

Related medicine news :

1. Detection at a distance for more sensitive MRI
2. Detection of glycoprotein could indentify ovarian and uterine cancers with poor prognosis
3. Detection of bioterrorism viruses brought closer to local sites
4. Detection of glucose intolerance after heart attack
5. Detection of glucose intolerance after heart attack could identify risk of cardiovascular disease
6. Millions Of Americans With Glaucoma Could Save Sight With Early Detection, Treatment
7. Microwaves May Provide Early Detection Of Breast Cancer
8. Learning From Experience: New Pattern Recognition & Detection Helps Radiologists Analyze Digital Mammograms
9. Could autoantibodies predict future disease in healthy people?
10. Mouse antibodies thwart SARS virus
11. Autoantibodies precede disease in lupus patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2020)... N.H. (PRWEB) , ... February 19, 2020 , ... ... been honored with a grant of $10,000.00 from the Doug Flutie, Jr. Foundation ... fitness program for students with autism. , The physical fitness program will include ...
(Date:2/19/2020)... ... February 19, 2020 , ... Actor, director, and producer, Laurence ... for his acting abilities demonstrated in blockbuster hits like the “John Wick” series, ... with Laurence Fishburne. “Behind The Scenes” features a broad array of topics. A ...
(Date:2/19/2020)... Mass. (PRWEB) , ... February 19, 2020 , ... ... the quality and consistency of healthcare delivery, announced that it will participate in ... 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other stakeholders ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... holding a CoolEvent for FDA-cleared CoolSculpting®, the world’s most popular non-invasive fat reduction ... Suite 850 in the Halcyon Village Center in Alpharetta, Georgia. The CoolEvent will ...
(Date:2/15/2020)... ... February 14, 2020 , ... UMF Corporation , a ... , a member of Prisma Health, providing a comprehensive PCPLUS program ... able to cut its monthly laundry management costs in half, support infection prevention, ...
Breaking Medicine News(10 mins):
(Date:2/19/2020)... ... ... Drs. Mario Canal and Ben Calem will host the Pinnacle Dental Study ... The course features guest speaker, Dr. Amanda Seay, and will focus on aesthetic dentistry ... full mouth dental implants, are a major focus at Canal Calem Periodontics as ...
(Date:2/19/2020)... Colo. (PRWEB) , ... February 19, 2020 , ... ... North America’s highest performing healthcare provider organizations with the release of its annual ... honorees stand out amongst North America’s premier hospitals for their ability to demonstrate ...
(Date:2/15/2020)... TAMPA, Fla. (PRWEB) , ... February 14, 2020 ... ... research has established an "oral-systemic” link between the organisms that cause inflammatory gum ... probiotics, from Tampa-based ProBiora Health?? , offers new tools in the fight ...
Breaking Medicine Technology:
Cached News: